Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from MicroTech Medical (Hangzhou) Co., Ltd. Class H ( (HK:2235) ).
MicroTech Medical (Hangzhou) Co., Ltd. held its Annual General Meeting (AGM) on May 28, 2025, where all proposed resolutions were passed by shareholders. The AGM included discussions on the reduction of registered capital and amendments to the Articles of Association. The resolutions, including the approval of the 2024 annual report and financial statements, were overwhelmingly supported by the shareholders, with over 99% voting in favor. This indicates strong shareholder confidence and positions the company for strategic adjustments in its capital structure.
The most recent analyst rating on (HK:2235) stock is a Sell with a HK$4.60 price target. To see the full list of analyst forecasts on MicroTech Medical (Hangzhou) Co., Ltd. Class H stock, see the HK:2235 Stock Forecast page.
More about MicroTech Medical (Hangzhou) Co., Ltd. Class H
MicroTech Medical (Hangzhou) Co., Ltd. is a joint stock company incorporated in China, operating within the medical industry. The company is focused on providing medical devices and solutions, with a particular emphasis on diabetes care and management products.
Average Trading Volume: 141,180
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.53B
For a thorough assessment of 2235 stock, go to TipRanks’ Stock Analysis page.